Africa's AI-driven economy must be built on a robust infrastructure that attracts capital and fuels sustainable growth, ...
Cassava will stop developing simufilam for Alzheimer’s this year after a Phase 3 trial failed to improve cognition and daily ...
On a busy morning in November 2024, a dramatic scene unfolded in a supermarket in Banani, Dhaka. Government officials, armed ...
The heavy selling pressure might have exhausted for Cassava Sciences (SAVA) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street ...
THE Guyana School of Agriculture (GSA) held its annual Food Science, Technology, and Agribusiness Management Exhibition on Monday, showcasing the innovation ...
Based in the Angolan capital of Luanda, on Africa’s southwest coast, FoodCare is a dried food manufacturer that processes and ...
Charles Schwab Investment Management Inc. cut its stake in shares of Cassava Sciences, Inc. (NASDAQ:SAVA – Free Report) by 11.6% in the 4th quarter, according to its most recent filing with the ...
U.S. stock indices slump amid tariff talks while healthcare sees major developments: J&J faces a $1.6B lawsuit, new FDA approvals, and a $2B ...
Cassava Sciences (NASDAQ:SAVA – Get Free Report)‘s stock had its “neutral” rating restated by HC Wainwright in a research report issued on Tuesday,Benzinga reports. They presently have a $2.00 target ...
The biotechnology company Cassava Sciences failed on Wednesday to end a malicious prosecution lawsuit by doctors and ...
President Donald Trump continues to warn of tariffs on the pharmaceutical industry; Susan Monarez replaces Dave Weldon as CDC ...
9d
Asianet Newsable on MSNCassava Sciences Stock Drops Over 30% After Alzheimer’s Drug Fails Study – But Retail Remains HopefulShares of Texas-based biotechnology company Cassava Sciences, Inc. (SAVA) tumbled 33% on Tuesday after the company reported ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results